200 patients recieved HM II LVAD during the study period; of these, 155 were BTT and 45 DT. There were a total of 300 BTT and 92 DT readmissions. DT patients were older (68 vs. 52 years) as compared to BTT patients (p<0.001). The median (range) readmissions was 1 (0-27) for BTT and 1 (0-19) for DT patients. The proportion of patients with any readmission was 51.6 % for BTT and 57.8 % for DT (p=0.5). The proportion with high recidivism ¡Ý4 readmissions) was 21 % for BTT and 11 % for DT (p=0.15). Gender, diagnosis, 6month, or 1year survival between the 2 groups were similar. 37.5 % of BTT patients were transplanted. The most frequent cause of readmission was infections (19 % BTT vs. 19.6 % DT) followed by bleeding (13 % BTT vs. 16.3 % DT). Readmission rates/100 persons implanted are shown in .
Patients who received DT LVAD were significantly older, but rate of readmissions was not different from BTT patients. Infection and bleeding were the most frequent cause for readmission. Strategies to reduce hospital readmissions are important to improve outcomes as well as quality of life in LVAD recipients.
BTT | DT | p | |
Age (Years) | 52¡À16 | 68¡À14 | .09 |
Gender ( % M) | 81.4 % | 57.8 % | .009 |
Infection | 37 | 40 | .6 |
All bleeding/anemia | 25 | 33 | .7 |
Hemolysis/thrombosis | 14 | 13 | .5 |
Arrhythmia | 4.5 | 2.2 | .2 |
Pacer/ICD issue | 12 | 6.7 | 0.2 |
Pump controller malfunction | 7.1 | 4.4 | .3 |
CHF exacerbation | 16 | 20 | .6 |